U.S. IPO Weekly Recap: Healthcare And Canadian Crosslistings Lead An 8 IPO Week

Summary

  • Eight IPOs joined the public market this past week, joined by ten SPACs.
  • Two companies postponed, both citing market conditions: fitness equipment brand iFIT Health & Fitness and drug developer AEON Biopharma.
  • New filers continued to flood the pipeline, with 22 IPOs and 12 SPACs submitting initial filings.

IPO (Initial public offering)

designer491/iStock via Getty Images

Eight IPOs joined the public market this past week, joined by ten SPACs. Two companies postponed, both citing market conditions: fitness equipment brand iFIT Health & Fitness (IFIT) and drug developer AEON

This article was written by

Renaissance Capital provides pre-IPO research to institutional investors and investment banks. The Firm manages two IPO-focused funds: The Renaissance IPO ETF (NYSE: IPO) and the Renaissance International IPO ETF (NYSE: IPOS). Individual investors can get a free overview of the IPO market on www.renaissancecapital.com, and try a free trial of our premium platform, IPO Pro (ipopro.renaissancecapital.com). Through Renaissance Capital’s pre-IPO research service, institutional investors get an independent opinion, in-depth fundamental analysis, and customizable financial models on all IPOs.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.